Technology Commercialization Office | Date: 2017-07-05
A collagen-based therapeutic delivery device includes an insoluble synthetic collagen-fibril matrix comprising a polymerization product of soluble oligomeric collagen or a polymerization product of a mixture of soluble oligomeric collagen with one or more type of non-oligomeric soluble collagen molecules, such as, for example, soluble telocollagen and/or soluble atelocollagen, and an active agent dispersed throughout the collagen-fibril matrix or within a portion of the collagen-fibril matrix. A pre-matrix composition includes an aqueous solution including soluble collagen-fibril building blocks and an active agent in the aqueous solution. The soluble collagen-fibril building blocks include soluble oligomeric collagen or a mixture of soluble oligomeric collagen with non-oligomeric soluble collagen molecules. The building blocks are operable to self-assemble into a macromolecular synthetic collagen-fibril matrix in the absence of an exogenous cross-linking agent. Methods of making and using the pre-matrix composition and the device are also provided.
News Article | March 2, 2017
WEST LAFAYETTE, Ind., March 02, 2017 (GLOBE NEWSWIRE) -- About 250 people packed the Herman and Heddy Kurz Purdue Technology Center for the recent Purdue Technology Showcase that featured dozens of pioneering innovations. The technology ranged from medical devices including a hands-free crutch design and an advanced wheelchair that converts to a walker, to analytical tools including an application that can interpret gang graffiti for law enforcement officials. The event featured 37 Purdue University innovators describing their innovations in four minutes or less before international company representatives, investors and entrepreneurs. They also had booth spaces where they could present their technologies to interested attendees in a more private fashion. All technologies presented are available for licensing through the Purdue Research Foundation Office of Technology Commercialization. “This event is allowing investors and business officials a chance to see just some examples of the wealth of Purdue-affiliated, novel technologies available for licensing,” said Brooke Beier, assistant director of the Purdue Office of Technology Commercialization, who organized the event. “It’s our goal to match these technologies with the appropriate corporate experts to make sure they can one day be made available to benefit the general public.” Michael Ladisch, distinguished professor of agricultural biological engineering, promoted his continuous cell concentration device that could make it possible to easily screen food or liquid samples for pathogens at food processing facilities. “This event gives researchers an opportunity to translate their technologies and meet investors and possible partners for such technologies in a very efficient way,” Ladisch said. “It’s very important to us because we’re working with the FDA, and this gives us another platform to let people know about the important technology.” Leaders from Nanovis, a Columbia City, Indiana-based life sciences company, were among the many attendees. The company develops implant systems that reduce fixation-related complications and infections for medical patients. “Long ago at a showcase like this we came upon the innovation, which we used to found Nanovis,” said company CEO Matt Hedrick. “These types of showcases give entrepreneurs and other business leaders a convenient look at the innovations coming out of Purdue University.” Anyone interested in learning more about any of the innovations listed below that are available for licensing through the Purdue Office of Technology Commercialization should call 765-588-3470 or email firstname.lastname@example.org A video of the presenting innovators is linked below following the innovators’ names: * Ed Delp, Click to view video: Improved Automatic Recognition and Interpretation of Gang Graffiti and Tattoos * William Graves and Kris Miller, Click to view video: Novel Wheelchair with Built-In Seat Lift and Integrated Walker * Rebecca Kramer and Michelle Yuen, Click to view video: System for Printing High-Deformation Sensors into Substrates * Hyowon Lee, Click to view video: Implantable Catheter for the Prevention of Cellular Occlusion * Herman Sintim c/o Joe Kasper, Click to view video: Therapeutic for Acute Myeloid Leukemia and other Cancers * Benxin Wu and Zheng Kang, Laser-Based Fabrication of Metal Nanocomposites onto Substrates The Purdue Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities. The office is managed by the Purdue Research Foundation, which received the 2016 Innovation and Economic Prosperity Universities Award for Innovation from the Association of Public and Land-grant Universities. For more information about funding and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at email@example.com. For more information on licensing a Purdue innovation, contact the Office of Technology Commercialization at firstname.lastname@example.org.
News Article | February 8, 2017
West Lafayette, Ind., Feb. 08, 2017 (GLOBE NEWSWIRE) -- A high-definition mobile virtual reality 3-D motion-tracking technology for fast, accurate and easy-to-use 3-D user interface can advance to the next level thanks to $100,000 in funding from investors. AccuPS LLC, a Purdue-affiliated startup, has developed the AeroWand™, an add-on 3-D motion-tracking controller that provides a way for mobile virtual reality (VR) users to interact in the VR space. The technology includes a head-tracking device, hand controller and transmitting antenna that plug into the user’s smartphone to enable the tracking signals. “A good analogy to what we are doing is providing a mouse to PC owners – without a mouse you can just see and watch, however with a mouse you are able to engage, take action and the overall experience is more exciting, useable and fun. That’s what the AeroWand aims to do,” said Byunghoo Jung, CEO and founder of AccuPS. “The benefit of our technology is that there is minimal set up with no wires or cameras to install. The device has a low-cost, inbuilt microprocessor that can locally compute the elegant and smart algorithms we developed, and it is very simple and easy to use.” Jung said the startup is pleased with the success of the first round of investment funding. “We’re very excited to receive these funds because it represents a vote of confidence from investors who are saying they believe in our product and its potential for success,” he said. “We had a lot of great interest in our product and the money we received motivates and inspires us to continue producing an elegant, high-tech product because we know it has the potential to provide a unique, exciting experience to mobile VR users.” AccuPS recently started a second round of investment funding, after beginning the first phase in spring 2016. The investments will put the group one closer to realization of the product. “With the money we raise our first priority is to make a commercial grade prototype that meets all the required and best proponent specs,” Jung said. “This will helps us present an actual product to potential customers so they can see how it actually works and line us up for potential partnerships or additional investments in the future.” AccuPS previously received a NSF STTR grant for $225,000. The company also received a $20,000 Elevate Purdue Foundry Fund Black Award in 2015. Technology used by AccuPS has been licensed through the Purdue Research Foundation Office of Technology Commercialization. The company is located in the Purdue Research Park of West Lafayette. AccuPS is a tech startup providing high definition 3D interaction solutions. The first product, AeroWand, is a 3D controller for virtual reality (VR) applications. The easy-to-use yet powerful 3D controller will make VR available to everyone at a low cost. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Established in 1930, the foundation accepts gifts; administers trusts; funds scholarships and grants; acquires property; protects Purdue's intellectual property; and promotes entrepreneurial activities on behalf of Purdue. The foundation manages the Purdue Foundry, Purdue Office of Technology Commercialization, Purdue Research Park and Purdue Technology Centers. The foundation received the 2016 Innovation and Economic Prosperity Universities Award for Innovation from the Association of Public and Land-Grant Universities. For more information about funding and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at email@example.com. The Purdue Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities. The office is managed by the Purdue Research Foundation, which received the 2016 Innovation and Economic Prosperity Universities Award for Innovation from the Association of Public and Land-grant Universities. For more information about funding and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at firstname.lastname@example.org. For more information on licensing a Purdue innovation, contact the Office of Technology Commercialization at email@example.com.
Technology Commercialization Office | Date: 2013-11-29
Various systems and methods may benefit from determination of environmental signatures in recordings. For example, such signatures may aid forensic analysis and alignment of media recordings, such as alignment of audio or video recordings. A method can include reading data representative of sensed light in a visual track of a video recording. The method can also include extracting an electric network frequency signal from the data representative of sensed light.
Technology Commercialization Office | Date: 2014-11-25
A formulation for coating surfaces, for example gloves, with a tacky film comprises a hydrophobically modified biopolymer, where the hydrophobic modifications of the biopolymer correspond to between 1 and 90% of available functional groups, a plasticizer, and a volatile solvent. The formulation quickly dries into a tacky film that provides an enhanced friction of the surface.
Technology Commercialization Office | Date: 2014-03-13
A hemostatic putty for treatment of a variety of wounds topographies, including but not limited to highly three dimensional wounds, for example gunshot wounds and impalements, is disclosed. The putty is comprised of a matrix polymer weakly crosslinked or not crosslinked such that a viscoelastic matrix is formed. The viscoelastic nature of the putty is tunable by the composition and enables the putty to conform to a variety of wound topographies. Likewise, a hemostatic polymer, for example chitosan or hydrophobically modified chitosan, is included in this matrix to impart hemostatic properties and tissue adhesive on the putty. The hemostatic polymers disclosed prevent microbial infection and are suitable for oxygen transfer required during normal wound metabolism.
Technology Commercialization Office, Childrens National Medical Center and The United States Of America | Date: 2013-10-17
The present invention relates to a biosensor capable of measuring the total concentration of one or a plurality of amino acids with the use of a reagentless system comprising an electrode modified by hydrogel that comprises at least one enzyme that oxidizes at least one substrate that is at least one amino acid. In some embodiments, the biosensor comprises a hydrogel comprising alginate. In some embodiments, the biosensor comprises use of a thermophilic bacterial metabolic enzyme immobilized or attached to the hydrogel.
Technology Commercialization Office | Date: 2011-05-04
A directive optical device includes an optically active material which may be a light emitting material or a light collecting material. A partially reflective grating is disposed proximate to the optically active material.
Technology Commercialization Office | Date: 2015-01-28
The present invention is directed to a hybrid high voltage aqueous electrolyte battery that combines Ni/Mg_(2)NiH_(4 )and Mg-ion rechargeable battery chemistries. The hybrid aqueous electrolyte battery can be used for plug-in hybrid electrical vehicles and electric vehicles.
Technology Commercialization Office | Date: 2011-07-26
A system and method for visually displaying and analyzing public health data for geospatial and/or time variations, including the collection of symptom data coupled with geographic and time data, filtering the symptom data based upon a selected time period and geographic range, and creating a visual result based upon statistical modeling including power transform and/or data normalization. According to at least one embodiment, the system for visually displaying and analyzing includes selecting and performing at least one aberration detection method such as applying CUSUM analysis, quantile measures, and/or bootstrapping analysis, and displaying the result to a user via a visual analytics arrangement.